Market Overview:
The global neurointerventional device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of neurological disorders, technological advancements, and increasing demand for minimally invasive procedures. Based on type, the embolic coils segment is expected to account for the largest share of the global neurointerventional device market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in this segment can be attributed to increasing demand for embolic coils for treatment of aneurysms and other cerebrovascular diseases. Based on application, hospitals are expected to account for the largest share of the global neurointerventional device market in 2018.
Product Definition:
A neurointerventional device is a medical device used to treat diseases or conditions of the brain, spine, and peripheral nervous system. These devices include catheters, stents, balloons, and coils. They are used to remove blood clots, repair damage caused by aneurysms or strokes, and relieve pressure on the spinal cord.
Embolic Coils:
Embolic coils are used in neurosurgery to treat brain aneurysms. It is a minimally invasive procedure wherein a coil is inserted into the blood vessel of the brain, which helps in coiling or uncoiling the aneurysm and sealing it permanently. The device works by changing its shape as it travels through the blood vessel wall thusly altering its electrical characteristics and providing enough energy to seal off any bleeding sites.
Neurovascular Stents (Carotid Stents and Intracranial Stents):
Neurovascular stents are used to treat aneurysms and arteriovenous malformations. The stent is placed in the affected blood vessel and helps in maintaining the blood flow through the artery or veins. Neurovascular stents are also called carotid or intracranial stents, as they are used for treating carotid artery aneurysm and intracranial arteries/veins malformation respectively.
Application Insights:
Based on application, the global market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of chronic diseases that require long-term treatment and management by interventional neuro surgeons coupled with increasing number of surgeries performed using these devices every year.
The others application segment includes clinics or hospitals that perform less than 20 procedures annually using embolic protection devices or embolic therapy for treating conditions such as aneurysms and arteriovenous malformations. Increasing awareness about these conditions has led to an increase in demand for minimally invasive treatments which have further increased adoption rates of neurointerventional devices among healthcare providers at low-volume clinics or hospitals across the globe.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high adoption rate for advanced technologies. The region is expected to maintain its dominance over the forecast period due to increasing incidence of stroke, which can be treated with neurointerventional devices. In addition, growing target population base and rising healthcare expenditure are also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure & availability of skilled neurosurgeons & interventionalists, supportive government initiatives pertaining toward treatment cost sharing programs along with favorable reimbursement policies by insurance companies coupled with rapidly growing economy especially in India & China are some other factors driving regional market growth. Moreover, increasing prevalence of diabetes is also expected drive demand for these procedures over next eight years (2030).
Growth Factors:
- Increasing incidence of neurological disorders: The global prevalence of neurological disorders is increasing at an alarming rate. This is primarily due to the aging population and the increased incidence of chronic diseases such as stroke, Alzheimer’s disease, and Parkinson’s disease. The Neurointerventional Device market is expected to benefit from this trend in the coming years.
- Technological advancements: The Neurointerventional Device market is witnessing rapid technological advancements, with new devices and therapies being developed constantly. This has led to an increase in the number of treatment options available for patients suffering from neurological disorders. This trend is likely to continue in the future, driving growth in the Neurointerventional Device market.
- Rising demand for minimally invasive procedures: There is a growing demand for minimally invasive procedures across all medical specialties due to their many advantages over traditional surgery such as reduced pain and blood loss, shorter hospital stays, and faster recovery times. The Neurointerventional Device market is benefiting from this trend as more neurosurgeons are adopting these devices for treating various neurological conditions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurointerventional Device Market Research Report
By Type
Embolic Coils, Neurovascular Stents (Carotid Stents and Intracranial Stents), Neurovascular Thrombectomy Devices, Intrasaccular Devices, Embolic Protection Devices, Others
By Application
Hospitals, Ambulatory Surgical Centers, Others
By Companies
Codman & Shurtleff, Integra Life Sciences, Medtronic, Stryker, Boston Scientific, BrainLab, Elekta, Karl Storz, Micromar, Scopis, Codman & Shurtleff, Abbott, Synapse Biomedical, Aesculap （B. Braun）, TeDan Surgical Innovations, Kogent Surgical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Neurointerventional Device Market Report Segments:
The global Neurointerventional Device market is segmented on the basis of:
Types
Embolic Coils, Neurovascular Stents (Carotid Stents and Intracranial Stents), Neurovascular Thrombectomy Devices, Intrasaccular Devices, Embolic Protection Devices, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Codman & Shurtleff
- Integra Life Sciences
- Medtronic
- Stryker
- Boston Scientific
- BrainLab
- Elekta
- Karl Storz
- Micromar
- Scopis
- Codman & Shurtleff
- Abbott
- Synapse Biomedical
- Aesculap （B. Braun）
- TeDan Surgical Innovations
- Kogent Surgical
Highlights of The Neurointerventional Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Embolic Coils
- Neurovascular Stents (Carotid Stents and Intracranial Stents)
- Neurovascular Thrombectomy Devices
- Intrasaccular Devices
- Embolic Protection Devices
- Others
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurointerventional Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A neurointerventional device (NID) is a medical device that is inserted into the brain to treat conditions such as epilepsy, stroke, and dementia.
Some of the major companies in the neurointerventional device market are Codman & Shurtleff, Integra Life Sciences, Medtronic, Stryker, Boston Scientific, BrainLab, Elekta, Karl Storz, Micromar, Scopis, Codman & Shurtleff, Abbott, Synapse Biomedical, Aesculap ¯Â¼Ë†B. Braun¯Â¼â€°, TeDan Surgical Innovations, Kogent Surgical.
The neurointerventional device market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neurointerventional Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neurointerventional Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neurointerventional Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neurointerventional Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neurointerventional Device Market Size & Forecast, 2018-2028
4.5.1 Neurointerventional Device Market Size and Y-o-Y Growth
4.5.2 Neurointerventional Device Market Absolute $ Opportunity
Chapter 5 Global Neurointerventional Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Neurointerventional Device Market Size Forecast by Type
5.2.1 Embolic Coils
5.2.2 Neurovascular Stents (Carotid Stents and Intracranial Stents)
5.2.3 Neurovascular Thrombectomy Devices
5.2.4 Intrasaccular Devices
5.2.5 Embolic Protection Devices
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Neurointerventional Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Neurointerventional Device Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neurointerventional Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neurointerventional Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Neurointerventional Device Analysis and Forecast
9.1 Introduction
9.2 North America Neurointerventional Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Neurointerventional Device Market Size Forecast by Type
9.6.1 Embolic Coils
9.6.2 Neurovascular Stents (Carotid Stents and Intracranial Stents)
9.6.3 Neurovascular Thrombectomy Devices
9.6.4 Intrasaccular Devices
9.6.5 Embolic Protection Devices
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Neurointerventional Device Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Neurointerventional Device Analysis and Forecast
10.1 Introduction
10.2 Europe Neurointerventional Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Neurointerventional Device Market Size Forecast by Type
10.6.1 Embolic Coils
10.6.2 Neurovascular Stents (Carotid Stents and Intracranial Stents)
10.6.3 Neurovascular Thrombectomy Devices
10.6.4 Intrasaccular Devices
10.6.5 Embolic Protection Devices
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Neurointerventional Device Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Neurointerventional Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Neurointerventional Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Neurointerventional Device Market Size Forecast by Type
11.6.1 Embolic Coils
11.6.2 Neurovascular Stents (Carotid Stents and Intracranial Stents)
11.6.3 Neurovascular Thrombectomy Devices
11.6.4 Intrasaccular Devices
11.6.5 Embolic Protection Devices
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Neurointerventional Device Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Neurointerventional Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Neurointerventional Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Neurointerventional Device Market Size Forecast by Type
12.6.1 Embolic Coils
12.6.2 Neurovascular Stents (Carotid Stents and Intracranial Stents)
12.6.3 Neurovascular Thrombectomy Devices
12.6.4 Intrasaccular Devices
12.6.5 Embolic Protection Devices
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Neurointerventional Device Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Neurointerventional Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Neurointerventional Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Neurointerventional Device Market Size Forecast by Type
13.6.1 Embolic Coils
13.6.2 Neurovascular Stents (Carotid Stents and Intracranial Stents)
13.6.3 Neurovascular Thrombectomy Devices
13.6.4 Intrasaccular Devices
13.6.5 Embolic Protection Devices
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Neurointerventional Device Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neurointerventional Device Market: Competitive Dashboard
14.2 Global Neurointerventional Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Codman & Shurtleff
14.3.2 Integra Life Sciences
14.3.3 Medtronic
14.3.4 Stryker
14.3.5 Boston Scientific
14.3.6 BrainLab
14.3.7 Elekta
14.3.8 Karl Storz
14.3.9 Micromar
14.3.10 Scopis
14.3.11 Codman & Shurtleff
14.3.12 Abbott
14.3.13 Synapse Biomedical
14.3.14 Aesculap （B. Braun）
14.3.15 TeDan Surgical Innovations
14.3.16 Kogent Surgical
